Press-release for stocks for sangamo therapeutics, inc. for sny

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Sangamo therapeutics, inc. symbols : Sny

save search

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -1.85% | O: -0.04% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -43.1% | O: 2.19% H: 4.55% C: -10.78%
business year therapeutics financial results

mRNA Vaccine Market to Reach $91.14 Billion by 2029
Published: 2023-01-24 (Crawled : 13:20) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310

|

Health Technology

| -4.57% | O: -0.27% H: 0.1% C: 0.1%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -2.88% | O: -0.72% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -85.76% | O: -0.87% H: 1.76% C: 1.17%
CVAC | $2.51 -3.46% -3.59% 1.1M

|

Health Technology

| -75.63% | O: -2.14% H: 4.07% C: 1.49%
vaccine mrna market

Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
EMMA | $0.1 8.58% 385.44% 4.6K

|

Professional, Scientific, and T...

| -70.44% | O: 33.02% H: 0.0% C: -21.11%
ARVL | News | $0.49 0.37% 2.5M

|

| 33.97% | O: -5.8% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M

|

Health Technology

| 14.76% | O: 0.74% H: 0.89% C: 0.53%
DHR | $250.41 -1.07% -0.63% 2.3M

|

Health Technology

| -3.93% | O: -0.32% H: 1.21% C: 0.09%
ABT | News | $106.89 -0.65% 0.07% 4.2M

|

Health Technology

| 2.91% | O: -0.13% H: 1.13% C: 0.14%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| 7.29% | O: 1.02% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -86.58% | O: -1.1% H: 1.66% C: -0.28%
ALNY | $143.8 -1.55% -1.58% 400K

|

Health Technology

| -33.84% | O: 0.22% H: 2.19% C: -5.13%
global report market

mRNA Vaccines and RNAi Therapeutics Market Report 2022: Government Initiatives for Large Scale Sequencing Projects Fueling Growth
Published: 2022-11-14 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310

|

Health Technology

| 4.88% | O: -1.6% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| 10.22% | O: 0.84% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -87.84% | O: -0.25% H: 1.49% C: -2.49%
report mrna therapeutics growth market

mRNA Vaccines and RNAi Therapeutics Market to Reach $12.31 Billion, Globally, by 2031 at 31.3% CAGR: Allied Market Research
Published: 2022-08-24 (Crawled : 10:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310

|

Health Technology

| 10.59% | O: -4.66% H: 0.0% C: -1.69%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| 15.9% | O: -1.48% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -91.22% | O: 0.18% H: 5.89% C: 4.65%
research mrna therapeutics market

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 23:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -2.86% | O: 1.09% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -89.79% | O: -0.42% H: 0.63% C: -0.21%
therapeutics results

Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

|

Health Technology

| -8.91% | O: 0.78% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -9.66% | O: -4.06% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -90.89% | O: -2.04% H: 0.0% C: 0.0%
financial results therapeutics report results

Sangamo Announces Transition of SAR445136 Sickle Cell Disease Program From Sanofi to Sangamo
Published: 2022-01-06 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

|

Health Technology

| -7.99% | O: 0.0% H: 0.0% C: -1.75%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -5.3% | O: 0.26% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -93.06% | O: -12.32% H: 11.95% C: 9.37%
sar4451 disease cel

BioSpace Movers & Shakers, Dec. 10
Published: 2021-12-10 (Crawled : 20:00) - biospace.com/
TLGTQ | $0.0002

|

| -99.41% | O: -2.06% H: 5.71% C: -6.01%
SNYNF | News | $94.0 -0.27% -2.18% 310

|

Health Technology

| 0.29% | O: 1.58% H: 2.9% C: 1.96%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -0.66% | O: 2.19% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -93.98% | O: 0.49% H: 0.0% C: 0.0%
MRNA | News S | $108.85 0.89% 0.85% 3M

|

Health Technology

| -61.9% | O: -17.85% H: 0.0% C: 0.0%
KPTI | $1.09 0.91% 1.2M

|

Health Technology

| -83.13% | O: -2.79% H: 0.0% C: 0.0%
space spac

Sangamo Therapeutics Reports Recent Business and Clinical Highlights and Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -9.13% | O: -0.42% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -94.43% | O: 7.39% H: 0.0% C: 0.0%
financial results results

Global Kidney Innovation Summit Accelerates International Consortium
Published: 2021-09-17 (Crawled : 23:00) - prnewswire.com
CDNA | $7.98 -3.04% -2.94% 760K

|

Health Technology

| Email alert Add to watchlist
BAX | $40.93 -0.22% 0.0% 2.2M

|

Health Technology

| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| Email alert Add to watchlist
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| Email alert Add to watchlist
kidney

BioSpace Movers & Shakers, July 9
Published: 2021-07-09 (Crawled : 15:15) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M

|

Health Technology

| -12.38% | O: 0.07% H: 0.0% C: 0.0%
GKOS | $100.93 -0.17% 0.0% 520K

|

Health Technology

| 30.79% | O: 0.98% H: 0.0% C: -1.87%
RARE F | $44.28 -1.84% -1.92% 670K

|

Health Technology

| -52.34% | O: 0.34% H: 0.06% C: -2.02%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -7.28% | O: 1.0% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -95.35% | O: 0.19% H: 1.71% C: 0.85%
CGNX | $39.53 -0.03% -0.05% 1.1M

|

Electronic Technology

| -53.37% | O: 0.74% H: 1.46% C: 1.37%
BMRN | $91.2 -0.93% -0.89% 1.3M

|

Health Technology

| 11.07% | O: 0.22% H: 0.71% C: 0.59%
space spac

Locanabio Expands Leadership Team with Appointment of Chief Scientific Officer and Chief Medical Officer
Published: 2021-07-06 (Crawled : 14:00) - biospace.com/
RARE F | $44.28 -1.84% -1.92% 670K

|

Health Technology

| -53.0% | O: -0.14% H: 1.39% C: -2.83%
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -8.9% | O: -1.0% H: 0.1% C: -0.25%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -95.82% | O: -0.34% H: 0.26% C: -3.6%
BMRN | $91.2 -0.93% -0.89% 1.3M

|

Health Technology

| 7.79% | O: -0.14% H: 0.0% C: -0.91%

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
Published: 2021-05-04 (Crawled : 22:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -6.77% | O: -0.33% H: 0.32% C: -0.59%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -95.79% | O: 1.81% H: 0.0% C: -4.05%
financial results results

Sangamo Announces EMA Releases Details Supporting Orphan Designation for BIVV003 for the Treatment of Sickle Cell Disease
Published: 2021-03-17 (Crawled : 23:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M

|

Health Technology

| -3.96% | O: -0.43% H: 0.0% C: -0.14%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

|

Health Technology

| -95.73% | O: -0.9% H: 4.25% C: 4.25%
disease treatment ema designation

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M

|

Consumer Services

BOF | $2.08 77.78% 41.21% 110M

|

ILAG | $0.54 12.27% 40.62% 3.7M

|

LICN | $0.999 78.39% 40.49% 15M

|

AMST | $3.4 70.0% 39.58% 70M

|

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M

|

Technology Services

WIMI | $1.15 58.53% 36.92% 19M

|

Technology Services

AIH | $0.458 14.5% 30.92% 91K

|

Health Services

WHLM | $6.25 35.87% 28.46% 700K

|

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M

|

Your saved searches

Save your searches and get alerts when important news are released.